E-LIB Suche - Ergebnisse für: Moura, Vera L

1

Targeted liposomal doxorubicin/ceramides combinations: The ..:

Cruz, Ana Filipa ; Fonseca, Nuno A. ; Malheiro, Ana Rita...
European Journal of Pharmaceutics and Biopharmaceutics. 172 (2022) - p. 61-77 , 2022

Link: https://doi.org/10.1016/..

2

Nucleolin Overexpression Predicts Patient Prognosis While P..:

Valério-Fernandes, Ângela ; Fonseca, Nuno A. ; Gonçalves, Nélio...
Cancers. 14 (2022) 9 - p. 2217 , 2022

Link: https://doi.org/10.3390/..

3

The Enhanced Efficacy of Intracellular Delivery of Doxorubi..:

Cruz, Ana F. ; Caleiras, Mariana B. ; Fonseca, Nuno A....
Cancers. 13 (2021) 12 - p. 3052 , 2021

Link: https://doi.org/10.3390/..

4

GMP-grade nanoparticle targeted to nucleolin downregulates ..:

Fonseca, Nuno A. ; Gregório, Ana C. ; Mendes, Vera M....
Nano Today. 37 (2021) - p. 101095 , 2021

Link: https://doi.org/10.1016/..

5

Modelling the impact of nucleolin expression level on the a..:

Lopes, Rui ; Shi, Kevin ; Fonseca, Nuno A....
Drug Delivery and Translational Research. 12 (2021) 3 - p. 629-646 , 2021

Link: https://doi.org/10.1007/..

6

Cell surface Nucleolin represents a novel cellular target f..:

Brignole, Chiara ; Bensa, Veronica ; Fonseca, Nuno A....
Journal of Experimental & Clinical Cancer Research. 40 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

7

Mindful Opportunity to Reflect on Experience: Interdiscipli..:

Barnhill, Jessica L ; Gerkin, Jonathan S ; Moura, Vera L.
Global Advances in Health and Medicine. 9 (2020) - p. 216495612090787 , 2020

Link: https://doi.org/10.1177/..

8

Lipid-Based Nanosystems for the Delivery of siRNA: Challeng..:

, In: Handbook of Nanomaterials for Cancer Theranostics,

Fonseca, Nuno A. ; Lopes, Rui M. ; Cruz, Ana F.... - p. 495-515 , 2018

Link: https://doi.org/10.1016/..

9

Contributors:

, In: Handbook of Nanomaterials for Cancer Theranostics,

Alonso-Nocelo, Marta ; Alvarez-Puebla, Ramon ; Bauleth-Ramos, Tomás... - p. xv-xvii , 2018

Link: https://doi.org/10.1016/..

10

Anticancer activity and antibody-dependent cell-mediated cy..:

Romano, Sofia ; Moura, Vera ; Simões, Sérgio..
Scientific Reports. 8 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

11

The cancer stem cell phenotype as a determinant factor of t..:

Fonseca, Nuno A. ; Cruz, Ana Filipa ; Moura, Vera..
Critical Reviews in Oncology/Hematology. 113 (2017) - p. 111-121 , 2017

Link: https://doi.org/10.1016/..

12

Inoculated Cell Density as a Determinant Factor of the Grow..:

Gregório, Ana C. ; Fonseca, Nuno A. ; Moura, Vera...
PLOS ONE. 11 (2016) 11 - p. e0165817 , 2016

Link: https://doi.org/10.1371/..

13

Nucleolin overexpression in breast cancer cell sub-populati..:

Fonseca, Nuno A. ; Rodrigues, Ana S. ; Rodrigues-Santos, Paulo...
Biomaterials. 69 (2015) - p. 76-88 , 2015

Link: https://doi.org/10.1016/..

14

Simultaneous active intracellular delivery of doxorubicin a..:

Fonseca, Nuno A. ; Gomes-da-Silva, Lígia C. ; Moura, Vera..
Journal of Controlled Release. 196 (2014) - p. 122-131 , 2014

Link: https://doi.org/10.1016/..

15

Lipid-Based Nanoparticles for siRNA Delivery in Cancer Ther..:

Gomes-da-Silva, Lígia C. ; Fonseca, Nuno A. ; Moura, Vera...
Accounts of Chemical Research. 45 (2012) 7 - p. 1163-1171 , 2012

Link: https://doi.org/10.1021/..